JFG
Jefferies Financial Group’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5M | Buy |
824,019
+192,126
| +30% | +$10.6M | 0.38% | 23 |
|
|
2025
Q1 | $30.6M | Sell |
631,893
-857,602
| -58% | -$41.5M | 0.27% | 35 |
|
|
2024
Q4 | $57.5M | Sell |
1,489,495
-325,201
| -18% | -$12.6M | 0.34% | 28 |
|
|
2024
Q3 | $81.7M | Sell |
1,814,696
-225,865
| -11% | -$10.2M | 0.58% | 11 |
|
|
2024
Q2 | $70.7M | Buy |
2,040,561
+860,000
| +73% | +$29.8M | 0.75% | 9 |
|
|
2024
Q1 | $34.2M | Sell |
1,180,561
-90,000
| -7% | -$2.6M | 0.32% | 20 |
|
|
2023
Q4 | $29.1M | Buy |
1,270,561
+435,000
| +52% | +$9.97M | 0.19% | 26 |
|
|
2023
Q3 | $13.9M | Buy |
835,561
+75,000
| +10% | +$1.25M | 0.13% | 48 |
|
|
2023
Q2 | $21M | Buy |
+760,561
| New | +$21M | 0.19% | 38 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$1.09M | – | 1359 |
|
|
2022
Q4 | $1.09M | Buy |
+100,000
| New | +$1.09M | 0.01% | 491 |
|